In a filing, Climb Bio Inc revealed its CHIEF ACCOUNTING OFFICER Pimblett Emily unloaded Company’s shares for reported $9741.0 on Sep 20 ’24. In the deal valued at $8.18 per share,1,191 shares were sold. As a result of this transaction, Pimblett Emily now holds 7,564 shares worth roughly $26549.64.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Morisset Valerie sold 69,005 shares, generating $554,170 in total proceeds. Upon selling the shares at $8.03, the EVP, R&D AND CSO now owns 31,317 shares.
Before that, Morisset Valerie sold 60,201 shares. Climb Bio Inc shares valued at $434,325 were divested by the EVP, R&D AND CSO at a price of $7.21 per share. As a result of the transaction, Morisset Valerie now holds 100,322 shares, worth roughly $0.35 million.
Price Performance Review of CLYM
On Monday, Climb Bio Inc [NASDAQ:CLYM] saw its stock fall -8.12% to $3.51. Over the last five days, the stock has lost -14.60%. Climb Bio Inc shares have risen nearly 30.00% since the year began. Nevertheless, the stocks have risen 35.00% over the past one year. While a 52-week high of $11.55 was reached on 05/03/24, a 52-week low of $2.35 was recorded on 04/05/24. SMA at 50 days reached $5.92, while 200 days put it at $5.61.
Levels Of Support And Resistance For CLYM Stock
The 24-hour chart illustrates a support level at 3.34, which if violated will result in even more drops to 3.16. On the upside, there is a resistance level at 3.84. A further resistance level may holdings at 4.16. The Relative Strength Index (RSI) on the 14-day chart is 19.88, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.66, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 98.88%. Stochastics %K at 1.68% indicates the stock is a buying.
How much short interest is there in Climb Bio Inc?
A steep rise in short interest was recorded in Climb Bio Inc stocks on 2024-10-15, growing by 3.57 million shares to a total of 4.7 million shares. Yahoo Finance data shows the prior-month short interest on 2024-08-30 was 1.13 million shares. There was a rise of 75.88%, which implies that there is a positive sentiment for the stock.
